ACACB | Acetyl-CoA carboxylase beta | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADH1B | Alcohol dehydrogenase 1B (class I), beta polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
ADIPOQ | Adiponectin, C1Q and collagen domain containing | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ANGPTL4 | Angiopoietin-like 4 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
APOD | Apolipoprotein D | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BOK | BCL2-related ovarian killer | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CALB2 | Calbindin 2 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CCL18 | Chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CFD | Complement factor D (adipsin) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
CNTFR | Ciliary neurotrophic factor receptor | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CXCL3 | Chemokine (C-X-C motif) ligand 3 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ECM2 | Extracellular matrix protein 2, female organ and adipocyte specific | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FABP4 | Fatty acid binding protein 4, adipocyte | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
FAM47E-STBD1 | FAM47E-STBD1 readthrough | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
FASN | Fatty acid synthase | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
GPD1 | Glycerol-3-phosphate dehydrogenase 1 (soluble) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
IGFBP6 | Insulin-like growth factor binding protein 6 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IL2RA | Interleukin 2 receptor, alpha | Cancer-related genes CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
IL6 | Interleukin 6 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LBP | Lipopolysaccharide binding protein | Plasma proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
LEP | Leptin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
LPL | Lipoprotein lipase | Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
MLXIPL | MLX interacting protein-like | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins Transcription factors
| | | | | Group enriched |
MYOC | Myocilin, trabecular meshwork inducible glucocorticoid response | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PLIN1 | Perilipin 1 | Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
PLIN4 | Perilipin 4 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
PTX3 | Pentraxin 3, long | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SAA1 | Serum amyloid A1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SAA2 | Serum amyloid A2 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SLC25A18 | Solute carrier family 25 (glutamate carrier), member 18 | Mitochondrial proteins Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
SOD3 | Superoxide dismutase 3, extracellular | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
THBS4 | Thrombospondin 4 | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
TIMP4 | TIMP metallopeptidase inhibitor 4 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
TNN | Tenascin N | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |